WBR0485: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor={{Rim}}
|QuestionAuthor={{Rim}}, {{AJL}} {{Alison}}
|ExamType=USMLE Step 1
|ExamType=USMLE Step 1
|MainCategory=Pathology, Pathophysiology
|MainCategory=Pathology, Pathophysiology
Line 20: Line 20:
|MainCategory=Pathology, Pathophysiology
|MainCategory=Pathology, Pathophysiology
|SubCategory=Hematology
|SubCategory=Hematology
|Prompt=An 18 month old boy was brought to an outpatient hematology department with complaints of pallor since birth. The child had a history of several hospital admissions for severe pallor and had been receiving blood transfusions every couple of months as of 2 months of age. History was negative for fever, bleeding, or jaundice. He had met all his milestones and was developing normally. The patient's family had recently migrated from Pakistan, and the mother denies any similar manifestations in the family. On physical exam, the physician notices pallor, frontal bossing, and hepatomegaly 4 cm below the costal margin. Exam was negative for icterus, lymphadenopathy, cyanosis, or clubbing. Blood work-up is significant for anemia (Hb= 6.7 g/dL) and the findings on blood smear shown below. What is the most likely mutation associated with the patient's condition?
|Prompt=An 18-month-old male is brought to an outpatient hematology department with pallor, beginning upon birth. The child has been admitted to the hospital multiple times for severe pallor and receives blood transfusions every couple of months, beginning when he was 2-months-old. He has been developing normally. The patient's family had recently migrated from Pakistan, and the mother denies any similar manifestations in the family. Upon physical exam, you note pallor, frontal bossing, and hepatomegaly, 4 cm below the costal margin. Blood work-up is significant for anemia (Hb= 6.7 g/dL) and the findings upon blood smear are illustrated below. Which of the following mutations is most likely associated with the patient's condition?




[[Image:WBR0485.JPG|500px]]
[[Image:WBR0485.JPG|500px]]
|Explanation=Congenital sideroblastic anemia is an inherited disease characterized by hypochromic microcytic anemia, iron overload, and ringed sideroblasts on blood smear and bone marrow biopsy. Although the inheritance pattern can be very heterogeneous, the most common presentation is X-linked secondary to a mutation in the ALAS2 gene producing a defective ALA synthase enzyme. Since ALA synthase catalyses the first step in heme synthesis, deficiency leads to a decrease in heme synthesis and mitochondrial iron accumulation manifesting as ringed sideroblasts. The anemia usually responds to oral vitamin B6 in most patients as pyridoxine is a key cofactor in the ALAS reaction. In general, the age at presentation, the severity of anemia, and the response to vitamin B6 are variable. Diagnosis depends on bone marrow biopsy or smear, HPLC, and blood iron work-up. Prussian blue staining is often needed to detect the iron rings. Prussian blue involves a non-enzymatic reaction of ferrous iron with ferrocyanide forming ferric-ferrocyanide, which is blue in color.


|Explanation=[[Congenital sideroblastic anemia]], an inherited disease, is characterized by [[hypochromic microcytic anemia]], iron overload, and ringed sideroblasts upon blood smear and bone marrow biopsy. The most frequently occurring pattern of inheritance is X-linked, secondary to a mutation in the ALAS2 gene, producing a defective ALA synthase enzyme. Since ALA synthase catalyses the first step in heme synthesis, deficiency leads to mitochondrial iron accumulation manifesting as ringed sideroblasts. [[Congenital sideroblastic anemia]] frequently is treated with oral vitamin B6, as pyridoxine is a key cofactor in the ALAS reaction. The age at presentation, severity of the anemia, and response to vitamin B6 vary. Diagnosis of [[Congenital sideroblastic anemia]] is dependent of on the findings of bone marrow biopsy or smear, HPLC, and blood iron work-up. Prussian blue staining is often used to detect the iron rings. Prussian blue involves a non-enzymatic reaction of ferrous iron with ferrocyanide, forming ferric-ferrocyanide, which is blue in color.


Educational objective: Congenital sideroblastic anemia is an inherited disease caused by a mutation in the ALAS2 gene producing a defective ALA synthase enzyme.
 
|EducationalObjectives= [[Congenital sideroblastic anemia]], an inherited disease caused by a mutation in the ALAS2 gene, produces a defective ALA synthase enzyme.
|References= Gupta SK, Rao S, Kar R, Tyagi S, Pati HP. Congenital sideroblastic anemia: A report of two cases. Indian J Pathol Microbiol 2009;52:424-6




Reference:<br>
Gupta SK, Rao S, Kar R, Tyagi S, Pati HP. Congenital sideroblastic anemia: A report of two cases. Indian J Pathol Microbiol 2009;52:424-6
|AnswerA=HbA Alpha-chain mutation
|AnswerA=HbA Alpha-chain mutation
|AnswerAExp=Alpha chain mutations are seen in alpha-thalassemia and do not cause ringed sideroblasts on blood smear.
|AnswerAExp=Alpha chain mutations, which do not cause ringed sideroblasts upon blood smear, are frequently observed in in [[alpha-thalassemia]].
|AnswerB=HbA Beta-chain mutation
|AnswerB=HbA Beta-chain mutation
|AnswerBExp=Beta chain mutations are seen in beta-thalassemia and do not cause ringed sideroblasts on blood smear.
|AnswerBExp=Beta chain mutations, which do not cause ringed sideroblasts upon blood smear, are frequently observed in [[beta-thalassemia]].
|AnswerC=Delta-ALA synthase mutation
|AnswerC=Delta-ALA synthase mutation
|AnswerCExp=Delta-ALA synthase mutations particularly X-linked ALAS2 gene mutations are responsible for congenital sideroblastic anemia.
|AnswerCExp=See explanation.
|AnswerD=Spectrin and Ankyrin mutations
|AnswerD=Spectrin and Ankyrin mutations
|AnswerDExp=Spectrin and Ankyrin mutations are seen in hereditary sperocytosis and do not cause ringed sideroblasts on blood smear.
|AnswerDExp=Spectrin and Ankyrin mutations, which do not cause ringed sideroblasts upon blood smear, are frequently observed in hereditary sperocytosis.
|AnswerE=Glucose-6-Phosphate Dehydrogenase mutaion
|AnswerE=Glucose-6-Phosphate Dehydrogenase mutaion
|AnswerEExp=Glucose-6-Phosphate Dehydrogenase mutations are seen in G6PD deficiency and do not cause ringed sideroblasts on blood smear.
|AnswerEExp=Glucose-6-Phosphate Dehydrogenase mutations, which do not cause ringed sideroblasts upon blood smear, are frequently observed in G6PD deficiency.
|RightAnswer=C
|RightAnswer=C
|WBRKeyword=Sideroblastic anemia, Sideroblasts, ALA synthase mutation
|WBRKeyword=Sideroblastic anemia, Sideroblasts, ALA synthase mutation, genetics, blood smear, inheritance, pattern of inheritance, mutations, X-linked
|Approved=No
|Approved=Yes
}}
}}

Revision as of 14:53, 29 July 2014

 
Author [[PageAuthor::Rim Halaby, M.D. [1], Alison Leibowitz [2] (Reviewed by Alison Leibowitz)]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Pathology, MainCategory::Pathophysiology
Sub Category SubCategory::Hematology
Prompt [[Prompt::An 18-month-old male is brought to an outpatient hematology department with pallor, beginning upon birth. The child has been admitted to the hospital multiple times for severe pallor and receives blood transfusions every couple of months, beginning when he was 2-months-old. He has been developing normally. The patient's family had recently migrated from Pakistan, and the mother denies any similar manifestations in the family. Upon physical exam, you note pallor, frontal bossing, and hepatomegaly, 4 cm below the costal margin. Blood work-up is significant for anemia (Hb= 6.7 g/dL) and the findings upon blood smear are illustrated below. Which of the following mutations is most likely associated with the patient's condition?


]]

Answer A AnswerA::HbA Alpha-chain mutation
Answer A Explanation [[AnswerAExp::Alpha chain mutations, which do not cause ringed sideroblasts upon blood smear, are frequently observed in in alpha-thalassemia.]]
Answer B AnswerB::HbA Beta-chain mutation
Answer B Explanation [[AnswerBExp::Beta chain mutations, which do not cause ringed sideroblasts upon blood smear, are frequently observed in beta-thalassemia.]]
Answer C AnswerC::Delta-ALA synthase mutation
Answer C Explanation AnswerCExp::See explanation.
Answer D AnswerD::Spectrin and Ankyrin mutations
Answer D Explanation AnswerDExp::Spectrin and Ankyrin mutations, which do not cause ringed sideroblasts upon blood smear, are frequently observed in hereditary sperocytosis.
Answer E AnswerE::Glucose-6-Phosphate Dehydrogenase mutaion
Answer E Explanation AnswerEExp::Glucose-6-Phosphate Dehydrogenase mutations, which do not cause ringed sideroblasts upon blood smear, are frequently observed in G6PD deficiency.
Right Answer RightAnswer::C
Explanation [[Explanation::Congenital sideroblastic anemia, an inherited disease, is characterized by hypochromic microcytic anemia, iron overload, and ringed sideroblasts upon blood smear and bone marrow biopsy. The most frequently occurring pattern of inheritance is X-linked, secondary to a mutation in the ALAS2 gene, producing a defective ALA synthase enzyme. Since ALA synthase catalyses the first step in heme synthesis, deficiency leads to mitochondrial iron accumulation manifesting as ringed sideroblasts. Congenital sideroblastic anemia frequently is treated with oral vitamin B6, as pyridoxine is a key cofactor in the ALAS reaction. The age at presentation, severity of the anemia, and response to vitamin B6 vary. Diagnosis of Congenital sideroblastic anemia is dependent of on the findings of bone marrow biopsy or smear, HPLC, and blood iron work-up. Prussian blue staining is often used to detect the iron rings. Prussian blue involves a non-enzymatic reaction of ferrous iron with ferrocyanide, forming ferric-ferrocyanide, which is blue in color.

Educational Objective: Congenital sideroblastic anemia, an inherited disease caused by a mutation in the ALAS2 gene, produces a defective ALA synthase enzyme.
References: Gupta SK, Rao S, Kar R, Tyagi S, Pati HP. Congenital sideroblastic anemia: A report of two cases. Indian J Pathol Microbiol 2009;52:424-6]]

Approved Approved::Yes
Keyword WBRKeyword::Sideroblastic anemia, WBRKeyword::Sideroblasts, WBRKeyword::ALA synthase mutation, WBRKeyword::genetics, WBRKeyword::blood smear, WBRKeyword::inheritance, WBRKeyword::pattern of inheritance, WBRKeyword::mutations, WBRKeyword::X-linked
Linked Question Linked::
Order in Linked Questions LinkedOrder::